Business
Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management
Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, a leading global healthcare company, at the 3rd China International Supply Chain Expo in Beijing. Leveraging its AI application services, innovative treatment solutions, and convenient pharmaceutical services, Fangzhou will collaborate with Novo Nordisk on managing serious chronic diseases, such as diabetes and obesity.
About this update from Fangzhou Inc.
[{"type":"text","content":"BEIJING, July 18, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, a leading global healthcare company, at the 3rd China International Supply Chain Expo in Beijing. Leveraging its AI application services, innovative treatment solutions, and convenient pharmaceutical services, Fangzhou will collaborate with Novo Nordisk on managing serious chronic diseases, such as diabetes and obesity.","length":535,"tagName":"p"},{"type":"image","alt":"Fangzhou Inc. (PRNewsfoto/Fangzhou Inc.)","displaySize":"","headline":null,"caption":"Fangzhou Inc. (PRNewsfoto/Fangzhou Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":127,"url":"https://media.zenfs.com/en/prnewswire.com/ec3b6ecc368092a3d079d531670f2342"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UzhMEweRObfFg12_yi_6IQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIyNDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/ec3b6ecc368092a3d079d531670f2342","width":400,"height":127}},"href":"https://mma.prnewswire.com/media/2544392/Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Fangzhou's founder, chairman, and CEO Dr. Xie Fangmin, and Christine Zhou, Novo Nordisk Senior Vice President & President of Region China, attended the signing ceremony.","length":177,"tagName":"p"},{"type":"text","content":"By leveraging Novo Nordisk's expertise and innovative products in diabetes and obesity treatment, Fangzhou plans to employ its smart healthcare ecosystem and robust technology infrastructure to create a comprehensive health management service. This will include medication guidance, reminders, efficacy tracking, and health education, effectively shaping the value chain in the glucose control and weight loss sector. The aim is to shift the focus from a "disease-centered" approach to a "health-centered" model, providing patients with higher quality and more convenient one-stop healthcare services.","length":635,"tagName":"p"},{"type":"text","content":"Dr. Xie Fangmin remarked, "We are partnering with Novo Nordisk, a leading global healthcare company, to explore AI technology and address the pain points of traditional health management. Together, we...